A Karolinska Institutet-led study has demonstrated that the use of an AI tool can enhance skin cancer diagnosis.

A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.

Fasikl has received 510(k) clearance from the FDA for its Felix NeuroAI Wristband, designed to address tremor-related functional ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

Philips has announced the expansion of its collaboration with Medtronic, focusing on advancing patient monitoring ...

Spiders can be an uncomfortable presence for many people but thanks to a new development, their silk is set to enhance nerve ...

Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...

The US FDA has granted 510(k) clearance to PathAI for its digital pathology image management system, AISight Dx.

With profound change in sight for the UK’s National Health Service (NHS), a new report indicates that a technology-driven ...

Fresenius Medical Care (FME) has collaborated with Mexico's CCINSHAE to extend HighVolumeHDF access to individuals.

InterShunt has initiated the EASE HF2 early feasibility study of the InterShunt percutaneous atrial shunt catheter (PAS-C) system.

Lunit is collaborating with Microsoft to help bring its AI-powered diagnostics for cancer detection into clinical practice.